{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T14:28:39Z","timestamp":1767018519942,"version":"3.48.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007834","name":"Ningbo Natural Science Foundation","doi-asserted-by":"crossref","award":["2021J251"],"award-info":[{"award-number":["2021J251"]}],"id":[{"id":"10.13039\/100007834","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007834","name":"Ningbo Natural Science Foundation","doi-asserted-by":"crossref","award":["2024J465"],"award-info":[{"award-number":["2024J465"]}],"id":[{"id":"10.13039\/100007834","id-type":"DOI","asserted-by":"crossref"}]},{"name":"One Health Interdisciplinary Research Project, Ningbo University","award":["HY202402"],"award-info":[{"award-number":["HY202402"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Parasites Vectors"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      The current therapeutic options for toxoplasmosis are limited by side effects. The development of molecules against\n                      <jats:italic>T. gondii<\/jats:italic>\n                      is urgently needed. A series of \u03b2-carboline derivatives were synthesized and examined as potential agents against toxoplasmosis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A series of \u03b2-carboline derivatives were synthesized. To assess their potential as anti-\n                      <jats:italic>T. gondii<\/jats:italic>\n                      agents, cytotoxicity towards Vero cells was determined using the CCK-8 assay. Plaque and qPCR assays were carried out to screen for anti-\n                      <jats:italic>T. gondii<\/jats:italic>\n                      activities, providing insights into their inhibitory effects on the parasite.\n                      <jats:italic>In vitro<\/jats:italic>\n                      assays on\n                      <jats:italic>T. gondii<\/jats:italic>\n                      RH and PRU strains were conducted to evaluate proliferation, invasion, and cyst formation. Transmission electron microscopy was employed to analyze ultrastructural changes and apoptosis in\n                      <jats:italic>T. gondii<\/jats:italic>\n                      , revealing the impact of the derivatives at the cellular level. Finally, the\n                      <jats:italic>in vivo<\/jats:italic>\n                      efficacy of the derivatives was tested in a mouse model, which offered valuable information on their potential therapeutic effects in a living organism.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      \u03b2-carboline derivatives exhibited potent inhibitory effects on the growth and replication of both PRU and RH strains, while demonstrating low cytotoxicity to mammalian cells. It is worth noting that NBZ023 and NBZ035 exhibited optimal potency against proliferation (IC\n                      <jats:sub>50<\/jats:sub>\n                      \u2009=\u20092.85 and 1.6\u00a0\u03bcM) or invasion (IC\n                      <jats:sub>50<\/jats:sub>\n                      \u2009=\u20094.72 and 1.13\u00a0\u03bcM) of\n                      <jats:italic>T. gondii<\/jats:italic>\n                      . Importantly, NBZ023 and NBZ035 had an\u00a0effect on preventing PRU cysts formation, and they markedly reduced parasite burden in the brain, spleen, and liver in mouse infection model.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Lead compounds NBZ023 and NBZ035 exhibited an excellent overall efficacy against the\n                      <jats:italic>T. gondii<\/jats:italic>\n                      RH and PRU strains, and were highly effective at preventing toxoplasmosis during murine infection, which are expected to be developed as new anti-toxoplasmosis drugs.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13071-025-07139-6","type":"journal-article","created":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T14:22:38Z","timestamp":1767018158000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Design, synthesis, and anti-Toxoplasma gondii evaluation of \u03b2-carboline derivatives"],"prefix":"10.1186","volume":"18","author":[{"given":"Zhendi","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yetian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyu","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongda","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuchao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weida","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiao","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zixun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weixin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jishan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongze","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jili","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,29]]},"reference":[{"key":"7139_CR1","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","volume":"363","author":"JG Montoya","year":"2004","unstructured":"Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004;363:1965\u201376.","journal-title":"Lancet"},{"key":"7139_CR2","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.tmrv.2016.03.002","volume":"30","author":"M Foroutan-Rad","year":"2016","unstructured":"Foroutan-Rad M, Majidiani H, Dalvand S, Daryani A, Kooti W, Saki J, et al. Toxoplasmosis in blood donors: a systematic review and meta-analysis. Transfus Med Rev. 2016;30:116\u201322.","journal-title":"Transfus Med Rev"},{"key":"7139_CR3","doi-asserted-by":"publisher","first-page":"6531","DOI":"10.1021\/acs.jmedchem.6b00760","volume":"59","author":"RSR Vidadala","year":"2016","unstructured":"Vidadala RSR, Rivas KL, Ojo KK, Hulverson MA, Zambriski JA, Bruzual I, et al. Development of an orally available and central nervous system (CNS) penetrant calcium-dependent protein kinase 1 (CDPK1) inhibitor with minimal human ether-a-go-go-related gene (hERG) activity for the treatment of toxoplasmosis. J Med Chem. 2016;59:6531\u201346.","journal-title":"J Med Chem"},{"key":"7139_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2020.104434","volume":"147","author":"T Nayeri","year":"2022","unstructured":"Nayeri T, Sarvi S, Moosazadeh M, Hosseininejad Z, Sharif M, Amouei A, et al. Relationship between toxoplasmosis and autism: a systematic review and meta-analysis. Microb Pathog. 2022;147:104434.","journal-title":"Microb Pathog"},{"key":"7139_CR5","first-page":"1847","volume":"67","author":"AA-O Amouei","year":"2020","unstructured":"Amouei AA-O, Moosazadeh MA-OX, Nayeri Chegeni TA-O, Sarvi SA-O, Mizani AA-O, Pourasghar MA-O, et al. Evolutionary puzzle of Toxoplasma gondii with suicidal ideation and suicide attempts: An updated systematic review and meta-analysis. Transbound Emerg Dis. 2020;67:1847\u201360.","journal-title":"Transbound Emerg Dis"},{"key":"7139_CR6","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1080\/20477724.2020.1738153","volume":"114","author":"TA-O Nayeri","year":"2020","unstructured":"Nayeri TA-O, Sarvi S, Moosazadeh MA-OX, Hosseininejad ZA-O, Amouei A, Daryani AA-O. Toxoplasma gondii infection and risk of attention-deficit hyperactivity disorder: a systematic review and meta-analysis. Pathog Glob Health. 2020;114:117\u201326.","journal-title":"Pathog Glob Health"},{"key":"7139_CR7","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2147\/DDDT.S60973","volume":"11","author":"H Alday","year":"2017","unstructured":"Alday H, Doggett J. Drugs in development for toxoplasmosis: advances, challenges, and current status. Drug Des Devel Ther. 2017;11:273\u201393.","journal-title":"Drug Des Devel Ther"},{"key":"7139_CR8","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s00381-023-05915-2","volume":"40","author":"A Caceres","year":"2024","unstructured":"Caceres A, Caceres-Alan A, Caceres-Alan T. Toxoplasma gondii infections in pediatric neurosurgery. Childs Nerv Syst. 2024;40:295\u2013301.","journal-title":"Childs Nerv Syst"},{"key":"7139_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2021.105070","volume":"158","author":"N Kalantari","year":"2021","unstructured":"Kalantari N, Gorgani-Firouzjaee T, Moulana Z, Chehrazi M, Ghaffari S. Toxoplasma gondii infection and spontaneous abortion: a systematic review and meta-analysis. Microb Pathog. 2021;158:105070.","journal-title":"Microb Pathog"},{"key":"7139_CR10","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1080\/20477724.2017.1370528","volume":"111","author":"SA-O Rajapakse","year":"2017","unstructured":"Rajapakse SA-O, Weeratunga PA-O, Rodrigo CA-O, de Silva NA-O, Fernando SA-O. Prophylaxis of human toxoplasmosis: a systematic review. Pathog Glob Health. 2017;111:333\u201342.","journal-title":"Pathog Glob Health"},{"key":"7139_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.ijpddr.2020.12.003","volume":"15","author":"CA Araujo-Silva","year":"2021","unstructured":"Araujo-Silva CA, De Souza W, Martins-Duarte ES, Vommaro RC. HDAC inhibitors tubastatin A and SAHA affect parasite cell division and are potential anti-Toxoplasma gondii chemotherapeutics. Int J Parasitol Drugs Drug Resist. 2021;15:25\u201335.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"7139_CR12","doi-asserted-by":"publisher","first-page":"6144","DOI":"10.1021\/acs.jmedchem.0c00419","volume":"63","author":"JW Janetka","year":"2020","unstructured":"Janetka JW, Hoppe AT, Yang ZP, Barks J, Dhason MS, Wang QL, et al. Optimizing pyrazolopyrimidine inhibitors of calcium dependent protein kinase 1 for treatment of acute and chronic toxoplasmosis. J Med Chem. 2020;63:6144\u201363.","journal-title":"J Med Chem"},{"key":"7139_CR13","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ejps.2018.02.018","volume":"117","author":"SJ Azami","year":"2018","unstructured":"Azami SJ, Amani A, Keshavarz H, Najafi-Taher R, Mohebalian M, Faramarzi MA, et al. Nanoemulsion of atovaquone as a promising approach for treatment of acute and chronic toxoplasmosis. Eur J Pharm Sci. 2018;117:138\u201346.","journal-title":"Eur J Pharm Sci"},{"key":"7139_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2021.104888","volume":"155","author":"N Yektaeian","year":"2021","unstructured":"Yektaeian N, Malekpour A, Atapour A, Davoodi T, Hatam G. Genetic immunization against toxoplasmosis: a review article. Microb Pathog. 2021;155:104888.","journal-title":"Microb Pathog"},{"key":"7139_CR15","doi-asserted-by":"publisher","first-page":"479","DOI":"10.2174\/092986707779940998","volume":"14","author":"R Cao","year":"2007","unstructured":"Cao R, Peng W, Wang Z, Xu A. Beta-Carboline alkaloids: biochemical and pharmacological functions. Curr Med Chem. 2007;14:479\u2013500.","journal-title":"Curr Med Chem"},{"key":"7139_CR16","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1021\/jm030475b","volume":"47","author":"M Yousaf","year":"2004","unstructured":"Yousaf M, Hammond NL, Peng JN, Wahyuono S, McIntosh KA, Charman WN, et al. New manzamine alkaloids from an Indo-Pacific sponge, pharmacokinetics, oral availability, and the significant activity of several manzamines against HIV-I, AIDS opportunistic infections, and inflammatory diseases. J Med Chem. 2004;47:3512\u20137.","journal-title":"J Med Chem"},{"key":"7139_CR17","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/1756-0500-6-193","volume":"6","author":"ML Alomar","year":"2013","unstructured":"Alomar ML, Rasse-Suriani FAO, Ganuza A, C\u00f3ceres VM, Cabrerizo FM, Angel SO. In vitro evaluation of \u03b2-carboline alkaloids as potential anti-Toxoplasma gondii agents. BMC Res Notes. 2013;6:193.","journal-title":"BMC Res Notes"},{"key":"7139_CR18","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.716534","volume":"12","author":"ML Alomar","year":"2021","unstructured":"Alomar ML, Ya\u00f1uk JG, Angel SO, Gonzalez MM, Cabrerizo FM. In vitro effect of harmine alkaloid and its N-methyl derivatives against Toxoplasma gondii. Front Microbiol. 2021;12:716534.","journal-title":"Front Microbiol"},{"key":"7139_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2021.114099","volume":"230","author":"X Wang","year":"2022","unstructured":"Wang X, Qiu H, Yang N, Xie H, Liang W, Lin J, et al. Fascaplysin derivatives binding to DNA via unique cationic five-ring coplanar backbone showed potent antimicrobial\/antibiofilm activity against MRSA in vitro and in vivo. Eur J Med Chem. 2022;230:114099.","journal-title":"Eur J Med Chem"},{"key":"7139_CR20","doi-asserted-by":"publisher","first-page":"4741","DOI":"10.1021\/acschemneuro.9b00503","volume":"10","author":"H Pan","year":"2019","unstructured":"Pan H, Qiu H, Zhang K, Zhang P, Liang W, Yang M, et al. Fascaplysin derivatives are potent multitarget agents against Alzheimer\u2019s disease: in vitro and in vivo evidence. ACS Chem Neurosci. 2019;10:4741\u201356.","journal-title":"ACS Chem Neurosci"},{"key":"7139_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2023.115348","volume":"254","author":"H Qiu","year":"2023","unstructured":"Qiu H, Zhao X, Jiang Y, Liang W, Wang W, Jiang X, et al. Design and synthesis of fascaplysin derivatives as inhibitors of FtsZ with potent antibacterial activity and mechanistic study. Eur J Med Chem. 2023;254:115348.","journal-title":"Eur J Med Chem"},{"key":"7139_CR22","doi-asserted-by":"publisher","first-page":"12978","DOI":"10.1002\/slct.201903444","volume":"4","author":"M Lin","year":"2019","unstructured":"Lin M, Liang W, Ma J, Wu Y, Xiao X, Ying J, et al. Efffcient and chemoselective amidation of betacarboline carboxylic acids. ChemistrySelect. 2019;4:12978\u201382.","journal-title":"ChemistrySelect"},{"key":"7139_CR23","doi-asserted-by":"publisher","first-page":"12363","DOI":"10.1002\/slct.201803007","volume":"3","author":"H Qiu","year":"2018","unstructured":"Qiu H, Liang W, Zhang G, Lin M, Liu W, Gao Z, et al. Aerobic oxidation of methyl-substituted beta-carbolines catalyzed by N-hydroxyphthalimide and metal catalyst. ChemistrySelect. 2018;3:12363\u20136.","journal-title":"ChemistrySelect"},{"key":"7139_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ijpddr.2018.12.004","volume":"9","author":"J Zhang","year":"2019","unstructured":"Zhang J, Si H, Shang X, Zhang X, Li B, Zhou X, et al. New life foran old drug: In vitro and in vivo effects of the anthelmintic drug niclosamide against Toxoplasma gondii RH strain. Int J Parasitol Drugs Drug Resist. 2019;9:27\u201334.","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"7139_CR25","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.3389\/fmicb.2019.02152","volume":"10","author":"J Zhang","year":"2019","unstructured":"Zhang J, Si H, Li B, Zhou X, Zhang J. Myrislignan exhibits activities against Toxoplasma gondii RH strain by triggering mitochondrial dysfunction. Front Microbiol. 2019;10:2152.","journal-title":"Front Microbiol"},{"key":"7139_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.684393","volume":"9","author":"J Zhang","year":"2021","unstructured":"Zhang J, Si H, Lv K, Qiu Y, Sun J, Bai Y, et al. Licarin-B exhibits activity against the RH Strain by damaging mitochondria and activating autophagy. Front Cell Dev Biol. 2021;9:684393.","journal-title":"Front Cell Dev Biol"},{"key":"7139_CR27","doi-asserted-by":"publisher","first-page":"753","DOI":"10.3389\/fmicb.2018.00753","volume":"9","author":"L Giovati","year":"2018","unstructured":"Giovati L, Santinoli C, Mangia C, Vismarra A, Belletti S, D\u2019Adda T, et al. Novel activity of a synthetic decapeptide against Toxoplasma gondii tachyzoites. Front Microbiol. 2018;9:753.","journal-title":"Front Microbiol"},{"key":"7139_CR28","doi-asserted-by":"publisher","first-page":"6361","DOI":"10.1128\/AAC.01236-15","volume":"59","author":"P Winzer","year":"2015","unstructured":"Winzer P, M\u00fcller J, Aguado-Mart\u00ednez A, Rahman M, Balmer V, Manser V, et al. In Vitro and In Vivo effects of the bumped kinase inhibitor 1294 in the related cyst-forming apicomplexans Toxoplasma gondii and Neospora caninum. Antimicrob Agents Chemother. 2015;59:6361\u201374.","journal-title":"Antimicrob Agents Chemother"},{"key":"7139_CR29","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1021\/acsmedchemlett.5b00319","volume":"6","author":"W Huang","year":"2015","unstructured":"Huang W, Ojo KK, Zhang Z, Rivas K, Vidadala RSR, Scheele S, et al. SAR Studies of 5-Aminopyrazole-4-carboxamide analogues as potent and selective inhibitors of Toxoplasma gondii CDPK1. ACS Med Chem Lett. 2015;6:1184\u20139.","journal-title":"ACS Med Chem Lett"},{"key":"7139_CR30","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s40001-021-00537-3","volume":"26","author":"S Sina","year":"2021","unstructured":"Sina S, Mohammad JM, Reza S, Anita M, Soudabeh E, Hadi M. Determination of parasitic burden in the brain tissue of infected mice in acute toxoplasmosis after treatment by fluconazole combined with sulfadiazine and pyrimethamine. Eur J Med Res. 2021;26:65.","journal-title":"Eur J Med Res"},{"key":"7139_CR31","doi-asserted-by":"publisher","first-page":"4843","DOI":"10.1128\/AAC.00462-10","volume":"54","author":"D Maubon","year":"2010","unstructured":"Maubon D, Bougdour A, Wong YS, Brenier-Pinchart MP, Curt A, Hakimi MA, et al. Activity of the histone deacetylase inhibitor FR235222 on: inhibition of stage conversion of the parasite cyst form and study of new derivative compounds. Antimicrob Agents Chemother. 2010;54:4843\u201350.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Parasites &amp; Vectors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-025-07139-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13071-025-07139-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13071-025-07139-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T14:22:39Z","timestamp":1767018159000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13071-025-07139-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,29]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7139"],"URL":"https:\/\/doi.org\/10.1186\/s13071-025-07139-6","relation":{},"ISSN":["1756-3305"],"issn-type":[{"type":"electronic","value":"1756-3305"}],"subject":[],"published":{"date-parts":[[2025,12,29]]},"assertion":[{"value":"23 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animals were maintained in a facility approved by the Association for Assessment and Accreditation of Laboratory Animal Care, and all the experiments were approved by the Animal Administration and Ethics Committee of the Lanzhou Institute of Husbandry and Pharmaceutical Sciences, Chinese Academy of Agricultural Sciences. The certificate number is SYXK (Gan) 2025\u201315.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"507"}}